US 2002/0164385 A1Published application

Treatment of HPV caused diseases

AssigneeCornell Research Foundation, Inc.

InventorsAndrew J. Dannenberg, Kotha Subbaramaiah

Life of this patent

Estimating the term…

Abstract

Human papillomavirus (HPV) protein expression is downregulated in patients infected with HPV by administration of PPARγ ligand, selective inhibitor of cyclooxygenase-2 (COX-2), diaryl heterocycle, inhibitor of HPV protein from a natural source and/or certain non-steroidal anti-inflammatory drugs.

Claims29

Dependent claims

A method of downregulating expression of HPV protein in a patient infected with an HP virus comprising administering to said patient a therapeutically effective amount of an inhibitor of the expression of HPV protein.

Dependencies are inferred from the claim text.

Facts

Application: 10/096,819Filed 14 Mar 2002
Priority: 3 May 2001
Published: 7 Nov 2002
Term ends: Not estimatedThe source records don’t support an estimate.

Classification10 codes

A61K 31/365
Having oxygen as the only ring hetero atom, e.g. fungichromin: lactones
A61K 31/00
Medicinal preparations containing organic active ingredients
A61K 31/415
Having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole: 1,2-Diazoles
A61K 31/425
Having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole: thiazoles

Family

Application60/288,107Us provisional application · filed 3 May 2001
US 7,183,316 B2Related patent
US 2002/0164385 A1This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results